Work

Abstract 3016: Ezh2 is a dose-dependent mediator of prostate cancer aggressiveness and lineage transformation

Year: 2018

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2018-3016

Authors: Kristine M. Wadosky, Yanqing Wang, Leigh Ellis, David W. Goodrich

Institutions: Roswell Park Comprehensive Cancer Center, Dana-Farber Cancer Institute

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2887294075

Cites:

Cited by: 1

Related to: 10